Stories
Delhi Woman's BRCA1 Mutation Prompts Aggressive Cancer Treatment, Risk-Reducing Surgeries
N
News18•01-10-2026, 19:30
Delhi Woman's BRCA1 Mutation Prompts Aggressive Cancer Treatment, Risk-Reducing Surgeries
- •A 40-year-old Delhi woman with triple-negative breast cancer was found to have a BRCA1 gene mutation, leading to a comprehensive treatment plan.
- •Sushma underwent eight cycles of chemotherapy and immunotherapy, responding well to the initial cancer treatment.
- •Genetic testing revealed a BRCA1 mutation, significantly increasing her risk of breast and ovarian cancers, prompting preventive measures.
- •She opted for a bilateral mastectomy with sentinel lymph node biopsy and a bilateral salpingo-oophorectomy to reduce future cancer risks.
- •Breast reconstruction using abdominal tissue was performed during the same surgical setting, integrating cancer treatment, risk reduction, and reconstructive surgery.
Key Questions Answered
The 40-year-old woman was diagnosed with triple-negative breast cancer and was found to carry a BRCA1 gene mutation.
Sushma underwent a bilateral mastectomy with a sentinel lymph node biopsy and a bilateral salpingo-oophorectomy to remove both ovaries and fallopian tubes, along with immediate breast reconstruction using abdominal tissue.
Genetic testing was recommended because of her relatively young age and family history of breast cancer.
